The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

Chikungunya is transmitted to humans through the bite of infected female mosquitoes, particularly Aedes aegypti and Aedes ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

Chikungunya isn't prevalent in the U.S., but travelers are being told to be cautious about getting the vaccine for the ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...

US health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible side effects.

Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

HEALTH. ED TO YOU. LET’S PICK IT UP RIGHT THERE. MARIA. HERE TO DISCUSS SOME MORE. IS DOCTOR TODD AND FAMILIAR FACE HERE AT 430 ON NEWSCENTER 5. CHIEF OF INFECTIOUS DISEASES AT SOUTH SHORE HEALTH.